Low case volume has been associated with poor outcomes in a wide spectrum of procedures. Our objective was to study the association of low case volume and worse outcomes in pediatric heart transplant centers, taking the novel approach of including waitlist outcomes in the analysis. We studied a cohort of 6482 candidates listed in the Organ Procurement and Transplantation Network for pediatric heart transplantation between 2002 and 2014; 4665 (72%) of the candidates underwent transplantation. Candidates were divided into groups according to the average annual transplantation volume of the listing center during the study period: more than 10, six to 10, three to five, or fewer than three transplantations. We used multivariate Cox regression analysis to identify independent risk factors for waitlist and posttransplantation mortality. Of the 6482 candidates, 24% were listed in low-volume centers (fewer than three annual transplantations). Of these listed candidates in low-volume centers, only 36% received a transplant versus 89% in high-volume centers (more than 10 annual transplantations) (p < 0.001). Listing at a low-volume center was the most significant risk factor for waitlist death (hazard ratio [HR] 4.5, 95% confidence interval [CI] 3.5-5.7 in multivariate Cox regression and HR 5.6, CI 4.4-7.3 in multivariate competing risk regression) and was significant for posttransplantation death (HR 1.27, 95% CI 1.0-1.6 in multivariate Cox regression). During the study period, one-fourth of pediatric transplant candidates were listed in low-volume transplant centers. These children had a limited transplantation rate and a much greater risk of dying while on the waitlist.
Low case volume has been associated with poor outcomes in a wide spectrum of procedures. Our objective was to study the association of low case volume and worse outcomes in pediatric heart transplant centers, taking the novel approach of including waitlist outcomes in the analysis. We studied a cohort of 6482 candidates listed in the Organ Procurement and Transplantation Network for pediatric heart transplantation between 2002 and 2014; 4665 (72%) of the candidates underwent transplantation. Candidates were divided into groups according to the average annual transplantation volume of the listing center during the study period: more than 10, six to 10, three to five, or fewer than three transplantations. We used multivariate Cox regression analysis to identify independent risk factors for waitlist and posttransplantation mortality. Of the 6482 candidates, 24% were listed in low-volume centers (fewer than three annual transplantations). Of these listed candidates in low-volume centers, only 36% received a transplant versus 89% in high-volume centers (more than 10 annual transplantations) (p < 0.001). Listing at a low-volume center was the most significant risk factor for waitlist death (hazard ratio [HR] 4.5, 95% confidence interval [CI] 3.5-5.7 in multivariate Cox regression and HR 5.6, CI 4.4-7.3 in multivariate competing risk regression) and was significant for posttransplantation death (HR 1.27, 95% CI 1.0-1.6 in multivariate Cox regression). During the study period, one-fourth of pediatric transplant candidates were listed in low-volume transplant centers. These children had a limited transplantation rate and a much greater risk of dying while on the waitlist.
Introduction
Cardiac surgery in children remains challenging, requiring significant surgical and multidisciplinary expertise, extensive hospital infrastructure, and focus. There is ongoing debate as to whether centers with a low annual pediatric cardiac surgery case volume can perform these procedures safely. Several studies have established a link between low case volume and inferior outcomes in congenital heart surgery (1-4).
The case-volume-outcome relationship is also known to apply to other complex surgical procedures (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) , including solid organ transplantation (17) (18) (19) (20) (21) (22) (23) and, more specifically, pediatric heart transplantation (24) . Other studies have shown a similar association in adult heart transplantation (19, 25, 26) . None of these studies, however, have explored waitlist outcome variability. In a recent analysis of pediatric liver transplantation, poor waitlist outcomes were observed in low-volume compared with higher-volume pediatric liver transplant centers (27) . The differences in waitlist mortality between high-and low-volume liver centers overshadowed the relatively minor posttransplantation outcome differences.
We aimed to investigate the dual perspectives of the relationships between center case volumes and waitlist and posttransplantation outcomes. We hypothesized that low-volume pediatric heart transplant centers would have inferior outcomes compared with higher-volume centers and that the most pronounced outcome differences would be on the waitlist.
Methods

Study population
We performed a retrospective analysis of the United Network for Organ Sharing (UNOS) deidentified patient-level data of all candidates listed for pediatric heart transplantation between March 1, 2002, and December 31, 2014. We analyzed the cardiac registry data collected from all transplant recipients younger than 18 years by the Organ Procurement and Transplantation Network (OPTN). Donor and recipient characteristics were reported at the time of transplantation, and followup information was collected at 6 months and yearly after transplantation. Patients undergoing combined or multivisceral transplantations and candidates placed on the waitlist for combined or multivisceral transplantations were excluded. A total of 6482 pediatric patients were followed from the date of listing; 4665 candidates received a heart transplant during the study period. This transplant cohort includes patients from the listing cohort who received a transplant during the study period.
Statistical analysis
We analyzed the data with the use of a standard statistical software package, Stata 9 (Stata Corp, College Station, TX). Continuous variables were reported as mean AE standard deviation and compared by using the Student's t-test. Contingency table analysis was used to compare categorical variables. Results were considered significant at p < 0.05, and all reported p-values were two-sided.
In our waitlist analysis, the date of death on the transplant list was established by the Social Security Death Master File and the UNOS death date. We used Kaplan-Meier analysis with log-rank test and Cox regression for time-to-event analysis. The primary outcome measure was waitlist death. Only patients who underwent transplantation were censored at the time of transplantation. All patients were followed from the time of listing to death (n = 827), transplantation (n = 4665), or last known follow-up (n = 990). The deaths of patients delisted for transplantation and lost to the database were captured with the Social Security Death Master File. Delisting did not factor into our end points of death or transplantation but may have an effect on date of last known follow-up. We also performed a competing risk regression analysis based on the method of Fine and Gray (1999) (28) , where transplantation was the competing outcome. The primary outcome was waitlist death. Candidates listed in programs that did not perform any transplantations in the study period were excluded from analysis.
In our intent-to-treat analysis, the primary outcome measure was death, regardless whether it was posttransplantation or waitlist death. All candidates were followed from time of listing (n = 6482) to time of death or last known follow-up, regardless of transplantation. UNOS death date and the Social Security Master Death File were used to establish death. Time to death was assessed as the time from date of listing to date of death.
In our posttransplantation survival analysis, we used Kaplan-Meier analysis with log-rank test and Cox regression for time-to-event analysis. The primary outcome measure was death after transplantation and time to death assessed by the time from transplantation to the date of death. Patients lost to follow-up (n = 89) or alive (n = 3393) on December 31, 2014, were censored at the date of last known follow-up. All recipients were followed from the date of transplantation to death (n = 1008) or last known follow-up (n = 3656). Only patients who received a transplant were included in the posttransplantation survival analysis. Time on the waitlist had no bearing on this analysis. Survival, either while on the waitlist or after transplantation, was the dependent variable, and risk factors were the independent variables in the regression analysis. Risk factors that were significant in univariate analysis (p < 0.05) were included in the multivariate analysis. Multivariate Cox regression was performed combining 100 bootstraps. We resampled observations with replacements from the data set 100 times in a method referred to as nonparametric bootstrapping. We confirmed the stability of the model by performing backward elimination and stepwise elimination using elimination based on a value of p > 0.05.
Risk factors
The pediatric heart transplantation volume for each center was defined as the average annual number of cases performed annually from 2002 to 2014. We defined low-volume centers as performing fewer than three transplantations per year. We performed a sensitivity analysis that showed that using four cases per year as the cutoff had a lower hazard ratio (HR) for waitlist mortality. Alternatively, using two cases per year was not significantly different than using three cases.
The other groups were categorized as rough multiples of 3-more than 10 cases, six to 10 cases, three to five cases, and fewer than three cases.
Using annual transplantation numbers during the study period as a categorization for our volume cohorts is problematic because transplantation is a competing outcome in our waitlist mortality analysis. We persisted with the use of annual transplantation numbers despite this limitation because it is more clinically relevant. Programs have traditionally been categorized by annual volume of transplantations. We did conduct a parallel analysis using annual listings per year instead of annual transplantations per year. The groups were constructed to correspond to our annual transplantation groups: more than 12, eight to 12, five to seven, and fewer than five listings per year. As expected, there was a strong correlation between annual listings and annual transplantations. We included 96% of the low-volume transplant programs in the low-volume listing cohort; the low-volume transplant cohort had 73 programs, while the low-volume listing cohort had 71 programs. We included 100% of the high-volume transplant programs in the high-volume listing cohort.
Recipient and donor risk factors considered in this analysis are listed in Table 1 . Creatinine clearance was calculated with use of the updated Schwartz bedside formula: estimated glomerular filtration rate = 0.41 9 height (cm)/serum creatinine (mg/dL).
Statistical tests based on scaled Schoenfeld residuals were performed to determine whether there were any significant changes in the variable effects over time. Among the time-dependent covariates, only two were statistically significant, with p-values <0.05 (under 1 year of age: À0.086, p = 0.015; and extracorporeal membrane oxygenation [ECMO]: À0.084, p = 0.011). These two factors were left as proportional hazards.
Center characteristics
We further characterized centers by identifying their hospital/programmatic environment. We categorized centers into three groups: pure pediatric centers (freestanding children's hospitals); combined adult/pediatric centers (children's hospital "within" an adult hospital), and adult centers (adult hospital performing pediatric heart transplantations). For adult centers, the analysis was limited to listed candidates younger than 18 years.
Adolescent candidates
We conducted a separate analysis of a total of 1675 teenaged candidates (13-18 years old).
Geographic inequities
To account for any geographic inequities in cardiac allograft distribution/ availability for transplantation, we performed univariate and multivariate regression analyses by using the UNOS region of listing as a covariate.
Missing variables
Missing variables were imputed using the predictive mean matching imputation method for incomplete predictors in the OPTN database (Table 1) . Our assumption was missing at random. This was not performed for ventricular assist devices (VADs) and previous sternotomy, because only the presence of the risk factor was reliably recorded.
Results
Study population
The study population at the time to transplantation and waitlist survival analysis consisted of 6428 patients.
Waitlist analysis consisted of 2847 patient-years at risk for the heart transplant recipients. Mean follow-up was 0.5 year. The study population for the posttransplantation survival analysis included 4665 patients. Posttransplantation survival analysis consisted of 19 603 patient-years at risk for the heart transplant recipients. Mean follow-up was 4.3 years. Demographic and clinical characteristics are summarized in Table 2 . Fourteen centers had an annual volume of more than 10 transplantations, 10 centers had six to 10 annual transplantations, 13 centers had three to five annual transplantations, and 73 centers had fewer than three annual transplantations. Among lower-volume centers, two centers in the category of fewer than three annual transplantations and one center with three to five annual transplantations had a standard deviation of higher than three. If these centers were removed from At the time of transplantation, candidates in low-volume centers were significantly older (mean age 9.5 years) and heavier (mean weight 40.6 kg) than candidates in highervolume centers (>10 annual cases, 6.5 years and 26.5 kg, respectively). A greater proportion of candidates in low-volume centers had a diagnosis of dilated cardiomyopathy (49.7% vs. 39.7%, p < 0.05).
Data entry rate
The data entry completion for variables is listed in Table 1 . Most variables were well populated. Multiple imputation with predicted mean values was performed for missing variables.
Percent transplanted (percentage of candidates who underwent transplantation during study period)
Centers that performed more than 10 transplantations per year had a transplantation rate of 89%; those with six to 10 transplantations per year, 83%; three to five transplantations per year, 69%; and fewer than three transplantations per year, 36% (p < 0.001 for each group compared with the high-volume centers). Figure 1 shows the dot plot of the percentage transplanted for each center's transplantation volume.
Waitlist survival analysis
We considered the recipient and center risk factors listed in Table 1 . The risk factors that were significant in multivariate analysis are presented in Table 3 . The most significant risk factors were listing in a center with transplantation volume of fewer than three cases per year (HR 4.5, 95% confidence interval [CI] 3.5-5.7) and previous heart transplantation (HR 2.4, 95% CI 1.9-3.1). The Kaplan-Meier analysis demonstrated significantly worse waitlist survival in low-volume centers-more than 10 transplantations per year: 91% 1-year survival, 79% 3-year survival, and 68% 5-year survival; six to 10 transplantations per year: 83% 1-year survival, 75% 3-year survival, and 71% 5-year survival; three to five transplantations per year: 79% 1-year survival, 69% 3-year survival, and 63% 5-year survival; and fewer than three transplantations per year: 58% 1-year survival, 48% 3-year survival, and 45% 5-year survival (p < 0.001 for each group compared with low-volume centers).
We conducted a parallel waitlist mortality analysis using annual listings to categorize our cohorts instead of number of annual transplantations. Figure 2A .
Competing outcomes for the first year after listing are illustrated in Figure 2B .
Intent-to-treat analysis
The most significant risk factors in our intent-to-treat analysis (survival regardless of transplantation for all listed candidates) were center volume of fewer than three cases per year (HR 2.2, 95% CI 1.9-2.4), previous transplantation (HR 2.0, 95% CI 1.7-2.4), ECMO (HR 1.5, 95% CI 1.3-1.8), and center volume of three to five cases per year (HR 1.4, 95% CI 1.2-1.6). Kaplan-Meier curves illustrating the intent-to-treat survival are depicted in Figure 3 .
Posttransplantation survival analysis
The risk factors that were significant in multivariate analysis are presented in Table 4 . The most significant risk factors were dialysis (HR 1.6, 95% CI 1.3-2.1), being African American (HR 1.6, 95% CI 1.4-1.8), and ECMO (HR 1.5, 95% CI 1.2-2.0). Center volume of fewer than three annual transplantations was also significant (HR 1.3, 95% CI 1.0-1.6). The Kaplan-Meier analysis revealed a significant difference between high-volume groups (more than 10 transplantations per year and six to 10 transplantations per year) and low-volume groups (fewer than three transplantations per year) (p = 0.004 and 0.001, respectively)-more than 10 transplantations per year: 90% 1-year survival, 83% 3-year survival, and 78% 5-year survival; six to 10 transplantations per year: 90% 1-year survival, 85% 3-year survival, and 80% 5-year survival; three to five transplantations per year: 89% 1-year survival, 84% 3-year survival, and 75% 5-year survival; and fewer than three transplantations per year: 89% 1-year survival, 80% 3-year survival, and 75% 5-year survival (Figure 4 ). Center effect Both categorizations of adult centers and combined adult/ pediatric centers were significant risk factors for waitlist mortality, but center volume designations remained dominant: adult center (HR 1.33, 95% CI 1.06-1.67) and combined adult/pediatric center (HR 1.33, 95% CI 1.10-1.67) compared with center volume of fewer than three transplantations per year (HR 4.48, 95% CI 3.52-5.71) and center volume of three to five transplantations per year (HR 2.17, 95% CI 1.68-2.81). Both adult centers and combined adult/pediatric center categorizations were not significant risk factors for posttransplantation survival.
Geographic inequities
When we included the UNOS region of listing in our multivariate Cox regression analysis for waitlist survival and posttransplantation survival in a parallel analysis, we found no significant differences in HR values for center volumes (data not shown).
Discussion
Previous analyses have suggested that low-volume pediatric heart transplantation centers have inferior posttransplantation outcomes, and this analysis did detect a modest difference in posttransplantation survival. (24) . In a novel finding, however, our study has demonstrated significant differences in waitlist outcomes. The percentage transplanted in low-volume centers was 36% compared with 89% in high-volume centers. Multivariate analysis reveals that the risk of dying while on the waitlist was >400% greater in low-volume centers (HR 4.5, 95% CI 3.5-5.7) compared with higher-volume centers. Of note, one-fourth (24%) of children are listed in low-volume centers. Lowvolume centers had modest differences in survival after transplantation compared with higher-volume centers.
Given currently available data in the OPTN database, it is difficult to speculate on the reasons behind these observations. There is an inference, based on data summarized in Table 2 , that lower-volume centers typically list lowerrisk patients, because recipients at low-volume centers were older, weighed more, and were more likely to have a diagnosis of dilated cardiomyopathy (least risky diagnosis). A significant number of low-volume centers are adult programs performing transplantations in adolescents. Our analysis of adolescent candidates revealed worse waitlist outcomes for the low-volume centers. Previous investigators suggested that the use of VADs on waitlisted candidates decreases waitlist mortality (29, 30) . We did not find any differences in the frequency of VAD use between low-and high-volume centers. We also found evidence that high-volume centers were more aggressive in donor selection. High-volume centers used a statistically greater number of ABO-incompatible donors, Centers for Disease Control high risk, and national share organs.
The lower transplantation rate in low-volume centers may be, in part, explained by the finding that a greater percentage of candidates die while on the waitlist (30% vs. 5% in high-volume centers, p < 0.05). Another interesting finding is that a greater percentage of candidates in low-volume centers are removed from the list because their condition improves (13% vs. 3% in high-volume centers, p < 0.05). This finding warrants further study. Although some studies challenge the relationship between low-volume centers and poor outcomes (31-33), a multitude of studies have suggested this association across a wide spectrum of procedures that range from the most complex and involved to the most routine (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . This is also true in the field of solid organ transplantation (17) (18) (19) (20) (21) (22) (23) . We conducted our analysis from a novel perspective: analyzing waitlist outcomes. This approach illustrates a larger concept in volume outcome analysis-the importance of preprocedural outcomes. Preprocedural and postprocedural outcomes should be analyzed in conjunction when conducting volume outcome analysis.
The reasons behind poor waitlist outcomes in lowvolume centers are not clear from review of the OPTN database. Further detailed studies using the OPTN database and sources beyond the database are needed to explore the deficit in low-volume center outcomes. Specifically, we need to examine the composition of the waitlists and corresponding listing practices, medical management, donor offers, and the application and management of exceptions. It is also important to note that many low-volume centers serve geographically isolated populations and are indispensable to maintain access to transplantation. Nonetheless, the findings in this analysis are important, because 24% of children are listed in low-pediatric volume cardiac transplant centers. It is also important to note that high-volume centers can absorb isolated bad outcomes within a larger cohort. This reality can mitigate the consequences for aggressive risk taking. At the very least, our observations suggest a need for increased scrutiny of waitlist outcomes. The Scientific Registry of Transplant Recipients routinely reports on waitlist mortality and transplantation rate, but centers rarely face independent inquiry on these outcomes.
Conclusion
During the study period, one-fourth of pediatric transplant candidates were listed in low-volume transplant centers. These children had a limited transplantation rate and a much greater risk of dying while on the waitlist.
Limitations
Since the passing of the National Transplantation Act of 1984, data entry has been mandatory for all U.S. transplant centers. Unfortunately, all patient registries still have variability in data entry. The findings from this study were based on large cohorts of patients and are unlikely to be significantly affected by small amounts of missing data. We attempted to account for missing data with predictive mean matching method. A significant limitation was that candidates who are delisted in one center and relisted in another were given another patient identification number and were not linked in this analysis. We tried to account for this by using the waitlist removal code designating transfer to another center. 
